Sponsor or institution

Clinical trials and research at Context Therapeutics Inc.

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• First-in-human test of CT-202, a nectin-4 directed bispecific antibody for recurrent TNBC, colorectal and urothelial cancers

  This phase 1a/1b study tests CT-202 to see if it is safe and tolerable and to get early signals of activity in patients with nectin-4–expressing recurrent or metastatic TNBC, colorectal cancer, or urothelial cancer who have exhausted standard therapies.

  Recruiting at 6 sites Phase 1 Context Therapeutics Inc. · Wahroonga, New South Wales and 5 other locations · NCT07545122

• Evaluating CTIM-76 for patients with recurring ovarian and other advanced cancers

  This study is testing a new treatment called CTIM-76 to see if it can help people with hard-to-treat ovarian and other advanced cancers feel better and live longer.

  Recruiting at 11 sites Phase 1 Context Therapeutics Inc. · Little Rock, Arkansas and 15 other locations · NCT06515613

Quick answers

How many clinical trials run by Context Therapeutics Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United Kingdom (1 trial), United States (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →